Fingerprint
Dive into the research topics of 'Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis
Nadera J. Sweiss, Imre Noth, Mehdi Mirsaeidi, Wei Zhang, Edward T. Naureckas, D. Kyle Hogarth, Mary Strek, Philip Caligiuri, Roberto F. Machado, Timothy B. Niewold, Joe G.N. Garcia, Aileen L. Pangan, Robert P. Baughman
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations